Laboratory Results Assessment
These laboratory results show several abnormalities that require attention: you have Stage 3a chronic kidney disease (CKD) confirmed by both creatinine-based and cystatin C-based GFR estimates, along with prediabetes/diabetes based on your glucose and HbA1c levels.
Kidney Function Analysis
Your kidney function shows concordant evidence of CKD:
- Creatinine-based eGFR: 83 mL/min/1.73 m² (mildly reduced)
- Cystatin C-based eGFR: 44 mL/min/1.73 m² (Stage 3a CKD)
- Cystatin C: 1.4 mg/L (elevated)
- Urine albumin: <0.12 mg/dL (normal - no albuminuria)
The discrepancy between your two GFR estimates is significant. According to KDIGO guidelines, when eGFR-creatinine falls in the 45-59 mL/min/1.73 m² range without albuminuria, cystatin C should be measured for CKD confirmation 1. However, your creatinine-based eGFR of 83 doesn't fall into this confirmatory range, yet your cystatin C-based eGFR of 44 clearly indicates Stage 3a CKD.
This represents confirmed CKD because your cystatin C-based eGFR is <60 mL/min/1.73 m² 1. The absence of albuminuria doesn't exclude CKD when GFR is reduced, as reduced eGFR without albuminuria is increasingly recognized in both type 1 and type 2 diabetes 2.
Glucose Metabolism Abnormalities
Your glucose control is abnormal:
- Fasting glucose: 126 mg/dL (diagnostic threshold for diabetes)
- HbA1c: 6.1% (prediabetes range: 5.7-6.4%)
You meet criteria for diabetes based on fasting glucose ≥126 mg/dL 3. While your HbA1c of 6.1% falls in the prediabetes range (not reaching the 6.5% diabetes threshold), the fasting glucose takes precedence. According to diabetes diagnostic criteria, you need confirmation with a repeat test, but a single fasting glucose ≥126 mg/dL in the context of your kidney disease strongly suggests diabetes 3.
Liver Function
Your liver tests are completely normal:
- ALT: 21 IU/L (normal: 19-33 IU/L) 4
- AST: 20 IU/L (normal range)
- Total bilirubin: 0.5 mg/dL (normal: <1.2 mg/dL)
- Direct bilirubin: 0.21 mg/dL (normal)
Lipid Profile
Your lipids are well-controlled:
- Total cholesterol: 152 mg/dL (optimal: <200 mg/dL)
- LDL: 90 mg/dL (near optimal: <100 mg/dL)
- HDL: 50 mg/dL (acceptable for men, optimal for women)
- Triglycerides: 77 mg/dL (optimal: <150 mg/dL)
- Non-HDL: 102 mg/dL (optimal: <130 mg/dL)
Clinical Implications and Actions Required
You need immediate referral to a nephrologist because your eGFR is <60 mL/min/1.73 m² (specifically 44 by cystatin C) 5, 2. The 2022 Diabetes Care guidelines recommend nephrologist referral when eGFR falls below 30 mL/min/1.73 m², but given the discrepancy between your two GFR estimates and your diabetes, earlier referral is warranted 5.
You also need diabetes management, including:
- Confirmation of diabetes diagnosis with repeat fasting glucose or HbA1c
- Initiation of diabetes treatment
- Blood pressure optimization (target <130/80 mmHg in CKD with diabetes) 5
- Consider ACE inhibitor or ARB if you develop albuminuria ≥30 mg/g creatinine 5, 2
Monitor these parameters at least annually 1:
- eGFR (both creatinine and cystatin C-based)
- Urine albumin-to-creatinine ratio
- HbA1c every 3 months until controlled, then every 6 months
- Blood pressure at every visit
Common Pitfalls to Avoid
The major pitfall here is dismissing the cystatin C-based GFR as a "false positive" because the creatinine-based GFR appears reassuring. Cystatin C is less affected by muscle mass, diet, and other non-renal factors that influence creatinine 1. Your cystatin C-based eGFR of 44 represents true kidney dysfunction requiring action, not observation.
Another pitfall is focusing only on the absence of albuminuria. CKD without albuminuria is increasingly common and carries significant cardiovascular and mortality risk 1, 2.